CARE-PC Study for Prostate Cancer and Heart Health

This study, called CARE-PC, is for men with prostate cancer who are receiving or will receive ADT (androgen deprivation therapy), a common treatment. It's testing a web-based application designed to help you understand your risk for heart problems and how to manage them. The app will provide education and personalized information about your heart health and prostate cancer. To join, you must be over 18, have prostate cancer, be on ADT for at least 6 months, and be able to read English. The main goal is to see how many people complete the web application over 18 months, which will help determine if this tool is useful for patients.

Study design
This is an interventional study planning to enroll 100 participants. It is a pilot feasibility study, meaning it's testing if the approach is practical.
What's involved
Participants will use the CARE-PC web-based application. The study aims to measure completion of the app over 18 months.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint for this study is measured at 18 months, indicating a follow-up period of at least that long.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06064149

The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study

Recruiting
NAAges 18+InterventionalHealth services
Vivek Narayan
~100 participants
Updated 2025-08-15 on ClinicalTrials.gov
What's tested:CARE-PC Web-Based Application

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
CARE-PC Web-Based Application Completion Rate
Measured over 18 months
Prostate Cancer
1 sites across 1 states
Pennsylvania1
  • Vivek Narayan, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Men with prostate cancer \> 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of ADT
Patients must be able to read and understand English.
  • CARE-PC Web-Based Application Completion Rate18 months

    Completion rate measured as the proportion of participants successfully completing the web-based application out of the total number of subjects approached.